当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 现金流量表

华北制药

(600812)

  

流通市值:107.92亿  总市值:107.92亿
流通股本:17.16亿   总股本:17.16亿

现金流量表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金7,556,833,074.365,594,132,346.93,702,753,296.21,806,040,642.14
收到的税费返还105,991,573.592,584,407.6554,333,492.4723,912,679.43
收到其他与经营活动有关的现金198,454,535.84504,202,062.14535,591,311.14443,304,305.29
经营活动现金流入的平衡项目0000
经营活动现金流入小计7,861,279,183.76,190,918,816.694,292,678,099.812,273,257,626.86
购买商品、接受劳务支付的现金3,294,331,239.882,604,852,414.661,742,928,867.72860,478,728.15
支付给职工以及为职工支付的现金1,358,374,747.08977,258,465.26644,246,623.81334,888,599.44
支付的各项税费495,020,001.28333,320,080.79224,029,649.94111,302,470.04
支付其他与经营活动有关的现金1,483,987,795.731,217,092,220.57798,290,158.42399,505,050.36
经营活动现金流出的平衡项目0000
经营活动现金流出小计6,631,713,783.975,132,523,181.283,409,495,299.891,706,174,847.99
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,229,565,399.731,058,395,635.41883,182,799.92567,082,778.87
二、投资活动产生的现金流量:
取得投资收益收到的现金710,914.98---
处置固定资产、无形资产和其他长期资产收回的现金净额1,270,1711,256,5001,256,500-
收到的其他与投资活动有关的现金510,004,532.06---
投资活动现金流入的平衡项目000-
投资活动现金流入小计511,985,618.041,256,5001,256,500-
购建固定资产、无形资产和其他长期资产支付的现金784,219,498.99481,875,355.35328,681,651.53192,682,233.74
投资支付的现金674,497,814.81---
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,458,717,313.8481,875,355.35328,681,651.53192,682,233.74
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-946,731,695.76-480,618,855.35-327,425,151.53-192,682,233.74
三、筹资活动产生的现金流量:
吸收投资收到的现金903,000,000903,000,000900,000,000-
其中:子公司吸收少数股东投资收到的现金900,000,000---
取得借款收到的现金9,793,745,0007,635,095,0004,851,475,0001,845,940,000
收到其他与筹资活动有关的现金1,004,700,416.67707,360,000707,360,000176,510,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计11,701,445,416.679,245,455,0006,458,835,0002,022,450,000
偿还债务支付的现金9,622,872,723.136,971,652,723.134,264,160,325.21,917,547,397.93
分配股利、利润或偿付利息支付的现金492,581,063.47391,688,722.05261,775,062.39118,501,797.36
其中:子公司支付给少数股东的股利、利润23,514,00022,102,00022,102,000-
支付其他与筹资活动有关的现金1,123,254,659.131,602,772,467.481,576,756,614.6475,793,117.81
筹资活动现金流出平衡项目0000
筹资活动现金流出小计11,238,708,445.738,966,113,912.666,102,692,002.192,511,842,313.1
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额462,736,970.94279,341,087.34356,142,997.81-489,392,313.1
四、汇率变动对现金及现金等价物的影响11,828,701.558,067,852.118,662,566.742,477,280.43
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额757,399,376.46865,185,719.51920,563,212.94-112,514,487.54
加:期初现金及现金等价物余额505,004,576.56505,004,576.56505,004,576.56505,004,576.56
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,262,403,953.021,370,190,296.071,425,567,789.5392,490,089.02
补充资料:
净利润214,966,518.33-97,495,559.68-
资产减值准备16,374,073.77--10,531,887.26-
固定资产和投资性房地产折旧635,679,352.84-313,947,674.18-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧635,679,352.84-313,947,674.18-
无形资产摊销157,305,834.77-68,215,137.49-
长期待摊费用摊销12,014,267.59-6,380,463-
处置固定资产、无形资产和其他长期资产的损失-444,156.56--438,809.62-
固定资产报废损失136,209.76---
财务费用458,698,019.11-238,700,837.64-
投资损失-46,164,658.18--22,288,412.5-
递延所得税8,779,495.24---
其中:递延所得税资产减少-20,324,237.19---
递延所得税负债增加29,103,732.43---
存货的减少94,320,345.95-41,315,198.7-
经营性应收项目的减少377,130,760.26-75,986,483.94-
经营性应付项目的增加-792,321,173.66-17,973,782.78-
现金的期末余额1,262,403,953.02-1,425,567,789.5-
减:现金的期初余额505,004,576.56-505,004,576.56-
公告日期2025-03-282024-10-262024-08-142024-04-26
审计意见(境内)标准无保留意见
TOP↑